Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
about
Epidermal growth factor receptor and notch signaling in non-small-cell lung cancerSyndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathwaysCombined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.Prospects for new lung cancer treatments that target EMT signaling.Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease.
P2860
Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Epidermal growth factor recept ...... n-small cell lung cancer cells
@en
type
label
Epidermal growth factor recept ...... n-small cell lung cancer cells
@en
prefLabel
Epidermal growth factor recept ...... n-small cell lung cancer cells
@en
P2093
P2860
P50
P1476
Epidermal growth factor recept ...... n-small cell lung cancer cells
@en
P2093
Achilleas D Theocharis
Angeliki Lampropoulou
Dimitra Kotsirilou
Efstathia Giannopoulou
Konstantinos Fasseas
Sofia Raftopoulou
Thomas Makatsoris
P2860
P2888
P356
10.1186/S12929-015-0196-1
P577
2015-10-24T00:00:00Z
P5875
P6179
1022153862